These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 9219791)
1. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791 [TBL] [Abstract][Full Text] [Related]
2. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India. Mittal RD; Bid HK; Ghoshal UC Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659 [TBL] [Abstract][Full Text] [Related]
3. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412 [TBL] [Abstract][Full Text] [Related]
4. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease. Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621 [TBL] [Abstract][Full Text] [Related]
6. [Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients]. Ma P; Chen D; Pan J; Du B Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1237-41. PubMed ID: 12425801 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837 [TBL] [Abstract][Full Text] [Related]
8. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968 [TBL] [Abstract][Full Text] [Related]
9. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease. Haas SL; Andreas Koch W; Schreiber S; Reinhard I; Koyama N; Singer MV; Böcker U Scand J Gastroenterol; 2005 Dec; 40(12):1438-43. PubMed ID: 16316892 [TBL] [Abstract][Full Text] [Related]
10. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases]. Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492 [TBL] [Abstract][Full Text] [Related]
11. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis. Schrijver HM; van As J; Crusius JB; Dijkstra CD; Uitdehaag BM Mediators Inflamm; 2003 Apr; 12(2):89-94. PubMed ID: 12775358 [TBL] [Abstract][Full Text] [Related]
12. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. Khazen D; Jendoubi-Ayed S; Aleya WB; Sfar I; Mouelhi L; Matri S; Najjar T; Filali A; Gorgi Y; Abdallah TB; Ayed K Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):167-75. PubMed ID: 19212205 [TBL] [Abstract][Full Text] [Related]
13. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710 [TBL] [Abstract][Full Text] [Related]
14. Is interleukin-6 important in inflammatory bowel disease? Koss K; Satsangi J; Welsh KI; Jewell DP Genes Immun; 2000 Feb; 1(3):207-12. PubMed ID: 11196713 [TBL] [Abstract][Full Text] [Related]
15. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease]. Waterman M; Karban A; Nesher S; Weiss B; Shamir R; Eliakim R Harefuah; 2006 Nov; 145(11):789-92, 864. PubMed ID: 17183946 [TBL] [Abstract][Full Text] [Related]
16. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Carter MJ; Jones S; Camp NJ; Cox A; Mee J; Warren B; Duff GW; Lobo AJ; di Giovine FS Genes Immun; 2004 Jan; 5(1):8-15. PubMed ID: 14735144 [TBL] [Abstract][Full Text] [Related]
17. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780 [TBL] [Abstract][Full Text] [Related]
18. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Cantor MJ; Nickerson P; Bernstein CN Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590 [TBL] [Abstract][Full Text] [Related]
19. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population. Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269 [TBL] [Abstract][Full Text] [Related]
20. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]